FDA classifies home‑collected STI nucleic‑acid detection system as Class II

Classification of a medical diagnostic device by the FDA

The provided event concerns regulatory classification of a medical device for detecting sexually transmitted infections. The candidate biblical passages relate to sacrificial rites, idolatry, and prophetic visions, none of which address the moral dimensions of regulatory actions, public health policy, or technological development. Consequently, there is insufficient scriptural context to evaluate the conduct as righteous or unrighteous.

The event is a secular regulatory matter without documented moral conduct in the supplied passages.

Only the supplied verses may be used; none directly speak to the ethics of FDA device classification or public health measures, so no moral judgment can be derived.